ChromaDex Corp (NAS:CDXC)
$ 7.64 0.05 (0.66%) Market Cap: 583.57 Mil Enterprise Value: 554.22 Mil PE Ratio: 764.00 PB Ratio: 16.90 GF Score: 73/100

Q3 2024 Chromadex Corp Earnings Call Transcript

Oct 31, 2024 / 08:30PM GMT
Release Date Price: $3.49 (-2.51%)
Operator

Thank you for standing by. My name is Mandeep and I'll be your operator today. At this time. I'd like to welcome everyone to the Chromadex third quarter, 2024 earnings conference call. All lines being placed on mute to prevent any background noise. After the Speaker presentation will be a question and answer session. If you'd like to ask a question during this time, simply press star followed by the number one on your telephone keypad. If you'd like to withdraw your question, press star one again. Thank you. I would now like to turn the call over to Ben Shamsian investor relations. You may begin.

Ben Shamsian
Chromadex Corp - Investor Relation

Thank you. Good afternoon and welcome to Chromadex Corporation's third quarter of 2024. Results investor call with us today are Chromadex's Chief Executive Officer, Robert Fried, Chief Financial Officer Ozan Pamir, and senior Vice President of Scientific and Regulatory Affairs. Dr. Andrew Shao. Doctor Shao will join the call for Q&A. Today's conference call, may include forward-looking statements including statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot